Stock listing
Dyadic International, Inc.
Selected listing: DYAI · NASDAQ · USD · US
Dyadic International, Inc. (NASDAQ:DYAI), Health Services. Latest release Aug 13, 2026: Dyadic International, Inc. Secures $2.9 Million Through Registered…
- Ticker
- NASDAQ:DYAI
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NASDAQ
- Currency
- USD
About Dyadic International, Inc.
The company focuses on developing and commercializing its proprietary technology for producing biologics and vaccines. Dyadic aims to enhance the efficiency and cost-effectiveness of biopharmaceutical manufacturing processes.
Latest news from Dyadic International, Inc.
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement
August 13, 2026
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
August 12, 2026
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
August 4, 2026
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
August 3, 2026
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
July 28, 2026
Events
Research Dyadic International, Inc.
Dyadic International, Inc. company profile
View the public company page for Dyadic International, Inc. on 6ix.
Dyadic International, Inc. news
Read company news and market updates connected to Dyadic International, Inc..
Dyadic International, Inc. investor events
Find investor webinars, events, and replay context for Dyadic International, Inc..